Please ensure Javascript is enabled for purposes of website accessibility
Could Old Vaccines for Other Germs Protect Against COVID-19?
gvw_ap_news
By Associated Press
Published 5 years ago on
April 14, 2020

Share

WASHINGTON — Scientists are dusting off some decades-old vaccines against other germs to see if they could provide a little stopgap protection against COVID-19 until a more precise shot arrives.

“This is still a hypothesis, it could be a very important tool to bridge this dangerous period until we have on the market a proper, specific vaccine.” — Dr. Mihai Netea of Radboud University Medical Center in the Netherlands

It may sound odd: Vaccines are designed to target a specific disease. But vaccines made using live strains of bacteria or viruses seem to boost the immune system’s first line of defense, a more general way to guard against germs. And history books show that sometimes translates into at least some cross-protection against other, completely different bugs.

There’s no evidence yet that the approach would rev up the immune system enough to matter against the new coronavirus. But given that a brand-new vaccine is expected to take 12 to 18 months, some researchers say it’s time to put this approach to a faster test, starting with a tuberculosis vaccine.

“This is still a hypothesis,” said Dr. Mihai Netea of Radboud University Medical Center in the Netherlands. But if it works, “it could be a very important tool to bridge this dangerous period until we have on the market a proper, specific vaccine.”

The World Health Organization issued a stern warning Monday not to use the TB vaccine against COVD-19, unless and until studies prove it works.

Already nearly 1,500 Dutch health care workers have rolled up their sleeves for one study that Netea’s team is leading. It uses that TB vaccine, named BCG, which is made of a live but weakened bacterial cousin of the TB germ.

Possibly Next in Line

In Australia, researchers hope to enroll 4,000 hospital workers to test BCG, too, and 700 already have received either the TB vaccine or a dummy shot. Similar research is being planned in other countries, including the U.S.

Possibly next in line: Oral polio vaccine, drops made of live but weakened polio viruses. The Baltimore-based Global Virus Network hopes to begin similar studies with that vaccine and is in talks with health authorities, network co-founder Dr. Robert Gallo told The Associated Press.

Rapid studies are needed to tell if there could be “long-ranging effects for any second wave of this,” said Gallo, who directs the Institute of Human Virology at the University of Maryland School of Medicine.

At the U.S. National Institutes of Health, researchers are in early discussions about proposals to study the TB and polio vaccines as a possible COVID-19 defense, said agency spokeswoman Jennifer Routh.

There’s a big caution: Live vaccines are risky for people with weakened immune systems, and shouldn’t be tried against COVID-19 outside of a research trial, said Dr. Denise Faustman, immunobiology chief at Massachusetts General Hospital, who is planning a TB vaccine study.

“You can’t just roll it out,” she stressed. But, “it’s kind of an amazing opportunity to prove or disprove this off-target effect.”

Photo of tuberculosis vaccines in 1947
FILE – This March 1931 file photo shows ampules of the BCG vaccine against tuberculosis in a laboratory at the Institute Pasteur in Paris, France. Dec. 2, 1947 file photo. Scientists are dusting off some decades-old vaccines against TB and polio to see if they could provide stopgap protection against COVID-19 until a more precise shot arrives. (AP Photo/Alfred Eisenstaedt)

The First Clues

Years ago, scientists began noticing with several live vaccines what Dr. Victor Nizet, an immune expert at the University of California San Diego School of Medicine, calls “an important curiosity that people have been interested in trying to harness.”

What about oral polio vaccine? Those clues emerged first from the former Soviet Union, said Konstantin Chumakov, a vaccine specialist at the U.S. Food and Drug Administration, who stressed he was not speaking on behalf of the FDA. His mother was a Soviet scientist who in the 1970s published research showing flu cases dropped markedly after oral polio vaccination.

BCG is given mostly to newborns in developing countries, and it offers only partial protection against TB, a bacterial infection. But observational studies showed during childhood, the vaccinated tots had better overall survival, including from respiratory viruses.

In 2018, Netea’s team published a more direct test. They showed BCG stimulates initial immune defenses enough that it at least partly blocked another virus given experimentally a month later.

What about oral polio vaccine? Those clues emerged first from the former Soviet Union, said Konstantin Chumakov, a vaccine specialist at the U.S. Food and Drug Administration, who stressed he was not speaking on behalf of the FDA. His mother was a Soviet scientist who in the 1970s published research showing flu cases dropped markedly after oral polio vaccination.

In 2015, Danish researchers also found some hints of cross-protection after oral polio vaccinations. The oral drops still are used in developing countries while the U.S. and other areas that have eliminated polio use the inactivated shot for routine childhood vaccines.

Different Kinds of Immunity

There are overlapping types of immune defenses. The usual goal of a vaccine is to prime the body to recognize a specific health threat and make antibodies able to fight back when that particular bug comes along.

But that takes time. So at the first sign of infection, a first line of foot soldiers — white blood cells — springs into action to fend off the invader in other ways, what’s called innate immunity. If they fail, then the body creates its more targeted special forces to join the fight.

BCG appears to be reprogramming innate immune cells so they can more readily eliminate the germ up front, said Netea, the Dutch researcher.

Scientists not involved in the effort to try these vaccines against COVID-19 say it’s worthwhile to test.

“The scientific rationale I think is quite logical,” said Nizet, the UC-San Diego immune specialist. “The unknown is whether coronaviruses are in the spectrum of things that are efficiently protected” by that first-line innate immunity.

Some scientists have theorized that countries with large BCG-vaccinated populations might fare better in the pandemic. But given problems with accurately counting the toll, it’s far too early to draw any conclusions, a caution the WHO reiterated Monday.

RELATED TOPICS:

DON'T MISS

What to Know About Pam Bondi, Trump’s New Pick for Attorney General

DON'T MISS

North Korean Leader Says Past Diplomacy Only Confirmed US Hostility

DON'T MISS

Democrats Strike Deal to Get More Biden Judges Confirmed Before Congress Adjourns

DON'T MISS

Newsom Gaslights on Potential Gas Price Hikes in Fresno Visit

DON'T MISS

Automakers to Trump: Please Require Us to Sell Electric Vehicles

DON'T MISS

President Biden Welcomes 2024 NBA Champion Boston Celtics to White House

DON'T MISS

Ohtani Makes History With 3rd MVP, Judge Claims 2nd AL Honor

DON'T MISS

Trump Chooses Pam Bondi for Attorney General Pick After Gaetz Withdraws

DON'T MISS

Average Rate on a 30-Year Mortgage in the US Rises to Highest Level Since July

DON'T MISS

Cutting in Line? American Airlines’ New Boarding Tech Might Stop You at Now Over 100 Airports

UP NEXT

Bomb Cyclone Kills 1 and Knocks Out Power to Over Half a Million Homes Across the Northwest US

UP NEXT

Volunteers Came Back to Nonprofits in 2023, After the Pandemic Tanked Participation

UP NEXT

New Study: Proposed Trump Tariffs Could Cost US Consumers $78 Billion a Year

UP NEXT

Riders Stuck in Midair for Over 2 Hours on Knott’s Berry Farm Ride

UP NEXT

Shouting Racial Slurs, Neo-Nazi Marchers Shock Ohio’s Capital

UP NEXT

More Logging Is Proposed to Help Curb Wildfires in the US Pacific Northwest

UP NEXT

Scientists Fear What’s Next for Public Health if RFK Jr. Is Allowed To ‘Go Wild’

UP NEXT

Warren Slams Biden Admin for Failing to Hold Israel Accountable on Gaza Aid

UP NEXT

Suicides in the US Military Increased in 2023, Continuing a Long-Term Trend

UP NEXT

New FDA Rules for TV Drug Ads: Simpler Language and No Distractions

Newsom Gaslights on Potential Gas Price Hikes in Fresno Visit

10 hours ago

Automakers to Trump: Please Require Us to Sell Electric Vehicles

11 hours ago

President Biden Welcomes 2024 NBA Champion Boston Celtics to White House

11 hours ago

Ohtani Makes History With 3rd MVP, Judge Claims 2nd AL Honor

11 hours ago

Trump Chooses Pam Bondi for Attorney General Pick After Gaetz Withdraws

12 hours ago

Average Rate on a 30-Year Mortgage in the US Rises to Highest Level Since July

12 hours ago

Cutting in Line? American Airlines’ New Boarding Tech Might Stop You at Now Over 100 Airports

12 hours ago

MLB Will Test Robot Umpires at 13 Spring Training Ballparks Hosting 19 Teams

12 hours ago

Death Toll in Gaza From Israel-Hamas War Passes 44,000, Palestinian Officials Say

13 hours ago

Jussie Smollett’s Conviction in 2019 Attack on Himself Is Overturned

13 hours ago

What to Know About Pam Bondi, Trump’s New Pick for Attorney General

NEW YORK — Pam Bondi, the former Florida attorney general, was chosen Thursday by Donald Trump to serve as U.S. attorney general hours after...

9 hours ago

9 hours ago

What to Know About Pam Bondi, Trump’s New Pick for Attorney General

10 hours ago

North Korean Leader Says Past Diplomacy Only Confirmed US Hostility

10 hours ago

Democrats Strike Deal to Get More Biden Judges Confirmed Before Congress Adjourns

10 hours ago

Newsom Gaslights on Potential Gas Price Hikes in Fresno Visit

President Joe Biden with Mary Barra, the chief executive of General Motors, at the Detroit Auto Show, Sept. 14, 2022. President-elect Donald Trump has promised to erase the Biden administration’s tailpipe rules designed to get carmakers to produce electric vehicles, but most U.S. automakers want to keep them. (Doug Mills/The New York Times)
11 hours ago

Automakers to Trump: Please Require Us to Sell Electric Vehicles

11 hours ago

President Biden Welcomes 2024 NBA Champion Boston Celtics to White House

11 hours ago

Ohtani Makes History With 3rd MVP, Judge Claims 2nd AL Honor

Former Florida Attorney General Pam Bondi, speaks before Republican presidential nominee former President Donald Trump arrives to speak at a campaign rally at First Horizon Coliseum, Saturday, Nov. 2, 2024, in Greensboro, NC. (AP/Alex Brandon)
12 hours ago

Trump Chooses Pam Bondi for Attorney General Pick After Gaetz Withdraws

Help continue the work that gets you the news that matters most.

Search

Send this to a friend